Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Multiple Myeloma 26Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma 14Hodgkin Disease 14Neoplasms, Plasma Cell 13Leukemia 13Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Myeloproliferative Disorders 8Leukemia, Myeloid, Acute 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Burkitt Lymphoma 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelomonocytic, Chronic 5Primary Myelofibrosis 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Hairy Cell 4Hematologic Neoplasms 4Waldenstrom Macroglobulinemia 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Prolymphocytic 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myeloid, Accelerated Phase 3

Interventions

sargramostim 2liposomal amphotericin B 2Voriconazole 2Therapeutics 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2thymoglobulin 1aldesleukin 1Valacyclovir 1Stem Cell Transplantation 1Rituximab 1Ribavirin 1Radiotherapy 1Proteasome Inhibitors 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Palivizumab 1Monatide (IMS 3015) 1Minocycline 1Methylprednisolone 1Methotrexate 1Lithium Carbonate 1Lithium 1Lenalidomide 1Interleukin-12 Subunit p35 1Interferon-alpha 1Immunomodulating Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Rituximab × Plasma cell × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡